Newly Approved Drug Therapies (330): Flonase Nasal Spray, GlaxoWellcome

Description of Medical Areas

About the FDA Approved Listings

Drugs Approved by the FDA

Drug Name: Flonase Nasal Spray

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: GlaxoWellcome
Approval Status: Approved November 1997
Treatment for: allergic rhinitis

General Information

Flonase nasal spray has been approved by the FDA for the treatment of seasonal and perennial allergic rhintis in children four years and older. This supplementary new dosage application represents an extension of the product to include younger children.

Back to Drug Listing

Drug listing last updated on June 20, 2008

Patient Resources: [ Trial Listing ] [ Notification Services ] [ Drug Directories ]
[ About Clinical Research ] [ Patient Resources ] [ Patient Bookstore ]
Professional Resources: [ Research Center Profiles ] [ Industry Provider Profiles ] [ Jobs in Clinical Research ]
[ Industry News ] [ Professional Resources ] [ Professional Bookstore ]
General: [ Search ] [ Site Map ] [ Your Privacy ] [ CW World ] [ Home ]